Filing Details

Accession Number:
0000899243-19-025423
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-10-10 16:52:38
Reporting Period:
2019-10-08
Accepted Time:
2019-10-10 16:52:38
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1629137 Global Blood Therapeutics Inc. GBT Air Transportation, Scheduled (4512) DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1053466 L Deval Patrick C/O Global Blood Therapeutics, Inc.
171 Oyster Point Blvd., Suite 300
South San Francisco CA 94080
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-10-08 5,357 $3.40 5,357 No 4 M Direct
Common Stock Disposition 2019-10-08 5,357 $45.05 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2019-10-08 5,357 $0.00 5,357 $3.40
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2025-04-08 No 4 M Direct
Footnotes
  1. 25% of the shares subject to this option vested and became exercisable on April 8, 2016, and the remaining shares subject to this option vested and became exercisable in 12 equal quarterly installments thereafter.